← Ablatotech Vitals
Anesthesiology EvidenceDigest

Anesthetic Management and Outcomes in Patients with Ehlers-Danlos Syndrome Undergoing General Anesthesia

Anesthesiology · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
November 17, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Ehlers-Danlos syndrome (EDS) presents unique anesthetic challenges due to connective tissue fragility, vascular risks, and autonomic dysfunction. General anesthesia in patients with EDS requires careful preoperative assessment, tailored intraoperative management, and vigilant postoperative monitoring to mitigate risks such as vascular rupture, joint dislocations, and hemodynamic instability. Current evidence, largely from case reports and small series, suggests that individualized anesthetic plans emphasizing gentle airway manipulation, avoidance of excessive vascular stress, and management of associated comorbidities like postural orthostatic tachycardia syndrome (POTS) can improve perioperative safety. However, high-quality prospective data remain limited, and anesthesiologists should maintain heightened vigilance and multidisciplinary collaboration when managing these patients.

Clinical bottom line

Ehlers-Danlos syndrome (EDS) presents unique anesthetic challenges due to connective tissue fragility, vascular risks, and autonomic dysfunction. General anesthesia in patients with EDS requires careful preoperative assessment, tailored intraoperative management, and vigilant postoperative monitoring to mitigate risks such as vascular rupture, joint dislocations, and hemodynamic instability. Current evidence, largely from case reports and small series, suggests that individualized anesthetic plans emphasizing gentle airway manipulation, avoidance of excessive vascular stress, and management of associated comorbidities like postural orthostatic tachycardia syndrome (POTS) can improve perioperative safety. However, high-quality prospective data remain limited, and anesthesiologists should maintain heightened vigilance and multidisciplinary collaboration when managing these patients.

What the evidence shows

EDS encompasses a heterogeneous group of heritable connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. The vascular subtype (vEDS) carries the highest risk of arterial rupture and bleeding complications, while hypermobile EDS (hEDS) often coexists with autonomic dysfunction such as POTS (Laserna et al., 2021). Anesthetic management must be customized according to EDS subtype and individual patient risk factors.

Laserna et al. (2021) describe perioperative management of EDS type III (hypermobility type) patients with POTS undergoing general anesthesia, highlighting the importance of preoperative autonomic evaluation and intraoperative hemodynamic monitoring to avoid hypotension and tachycardia. They emphasize gentle positioning to prevent joint dislocations and careful vascular access to minimize bleeding.

Case reports of cesarean delivery in pregnant patients with EDS (Aljuba Yahya et al., 2025; Fedoruk et al., 2016; Campbell et al., 2002) illustrate the complexity of anesthetic choices, balancing risks of neuraxial anesthesia against potential vascular fragility. Aljuba Yahya et al. (2025) report successful general anesthesia with meticulous airway management and avoidance of excessive neck extension. Campbell et al. (2002) and Fedoruk et al. (2016) discuss neuraxial anesthesia with caution in vascular EDS, underscoring the need for individualized risk assessment.

Ohshita et al. (2016) provide a broader overview of anesthetic considerations, recommending avoidance of invasive procedures when possible, use of ultrasound guidance for vascular access, and readiness to manage bleeding or vascular complications. They also note the importance of postoperative monitoring for delayed hemorrhage or hematoma formation.

Rosa et al. (2017) focus on vascular EDS during pregnancy, emphasizing multidisciplinary planning and preparedness for emergent vascular repair. Their findings reinforce the critical need for anesthesiologists to anticipate and promptly manage catastrophic vascular events.

Caveats and uncertainty

The evidence base for anesthetic management in EDS is predominantly composed of case reports and small case series, limiting generalizability. No randomized controlled trials or large prospective cohorts exist to define optimal anesthetic techniques or protocols. The heterogeneity of EDS subtypes and phenotypic variability complicates risk stratification.

Many reports focus on obstetric anesthesia, which may not fully extrapolate to other surgical contexts. The rarity of vascular EDS and its high mortality risk mean that anesthetic recommendations often rely on expert opinion rather than robust data. Additionally, autonomic dysfunction such as POTS in EDS patients is underrecognized and may be overlooked without targeted assessment.

There is also uncertainty regarding the safety of neuraxial anesthesia in vascular EDS, with some reports suggesting risk of vascular injury but others describing successful use with caution. The balance between risks of general anesthesia airway manipulation and neuraxial techniques remains individualized.

How this may change practice

Anesthesiologists should incorporate a thorough preoperative evaluation for EDS patients, including subtype identification, vascular risk assessment, and screening for autonomic dysfunction like POTS. Multidisciplinary collaboration with genetics, cardiology, and surgical teams is essential for comprehensive planning.

Intraoperative management should prioritize gentle handling to avoid joint injury, use ultrasound guidance for vascular access, and maintain stable hemodynamics with close monitoring. Preparation for potential vascular emergencies, including availability of blood products and vascular surgery backup, is prudent especially in vEDS.

Postoperative vigilance for bleeding, hematoma, and hemodynamic instability is critical. Anesthetic plans should be individualized, balancing risks of airway manipulation, neuraxial anesthesia, and vascular fragility. Documentation of anesthetic course and outcomes will help build the evidence base for future guidance.

This evidence digest underscores the need for further prospective studies and registries to better characterize anesthetic risks and optimal management strategies in EDS patients undergoing general anesthesia.


References

  1. Laserna A, et al. Perioperative Management of Ehlers-Danlos Type III Syndrome Associated With Postural Orthostatic Tachycardia in Patients Undergoing General Anesthesia. Cureus 2021; DOI:10.7759/cureus.19311
  2. Aljuba Yahya M, et al. Anesthetic Management of a Pregnant Patient With Ehlers-Danlos Syndrome Undergoing Elective Cesarean Delivery: A Case Report. Cureus 2025; DOI:10.7759/cureus.89400
  3. Ohshita Naohiro, et al. Anesthetic Management of a Patient With Ehlers-Danlos Syndrome. Anesthesia Progress 2016; DOI:10.2344/16-00003.1
  4. Fedoruk Kelly, et al. Anesthetic Management of a Parturient With Hypermobility Phenotype but Possible Vascular Genotype Ehlers-Danlos Syndrome. Obstetric Anesthesia Digest 2016; DOI:10.1097/01.aoa.0000504755.33991.fb
  5. Campbell Nicola, et al. Anesthetic management of a parturient with Ehlers Danlos syndrome type IV. Canadian Journal of Anesthesia 2002; DOI:10.1007/bf03017928
  6. Rosa Anne, et al. Vascular Ehlers-Danlos syndrom (vEDS): complications and anesthetic management during pregnancy. 2017.

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team